Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Revenue (2016 - 2025)

Cumberland Pharmaceuticals' Revenue history spans 16 years, with the latest figure at $13.7 million for Q4 2025.

  • For Q4 2025, Revenue rose 31.08% year-over-year to $13.7 million; the TTM value through Dec 2025 reached $44.5 million, up 17.57%, while the annual FY2025 figure was $44.5 million, 17.57% up from the prior year.
  • Revenue for Q4 2025 was $13.7 million at Cumberland Pharmaceuticals, up from $8.3 million in the prior quarter.
  • Across five years, Revenue topped out at $13.7 million in Q4 2025 and bottomed at $8.1 million in Q3 2021.
  • The 5-year median for Revenue is $10.1 million (2023), against an average of $10.0 million.
  • The largest annual shift saw Revenue dropped 18.92% in 2021 before it surged 41.38% in 2022.
  • A 5-year view of Revenue shows it stood at $8.3 million in 2021, then grew by 9.66% to $9.1 million in 2022, then rose by 10.55% to $10.1 million in 2023, then rose by 3.47% to $10.4 million in 2024, then surged by 31.08% to $13.7 million in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Revenue are $13.7 million (Q4 2025), $8.3 million (Q3 2025), and $10.8 million (Q2 2025).